(Total Views: 329)
Posted On: 11/09/2020 10:15:39 AM
Post# of 36551
I wouldn’t worry about Pfizer and a fast finish. See clinical study https://clinicaltrials.gov/ct2/show/NCT043687...amp;rank=1
They are an ethical company and the key take-a-ways are:
Study Design
Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 43998 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Prevention
Official Title: A PHASE 1/2/3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND, DOSE-FINDING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, IMMUNOGENICITY, AND EFFICACY OF SARS-COV-2 RNA VACCINE CANDIDATES AGAINST COVID-19 IN HEALTHY INDIVIDUALS
Actual Study Start Date : April 29, 2020
Estimated Primary Completion Date : June 13, 2021
Estimated Study Completion Date : December 11, 2022
I doubt they will risk their credibility by rushing any trial protocols.
Also their vaccine is based on RNA with its own set of problems https://www.nature.com/articles/s41586-020-2639-4
Personally, I see mRNA and Ii-key like a Ford Model T and a Rolls-Royce. Sure the Model T was first and it will get you from point A to point B, but which one would you rather drive/ride in? We will probably still have another year of mask wearing and social distancing. So play it safe, be smart and stay healthy!
They are an ethical company and the key take-a-ways are:
Study Design
Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 43998 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Prevention
Official Title: A PHASE 1/2/3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND, DOSE-FINDING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, IMMUNOGENICITY, AND EFFICACY OF SARS-COV-2 RNA VACCINE CANDIDATES AGAINST COVID-19 IN HEALTHY INDIVIDUALS
Actual Study Start Date : April 29, 2020
Estimated Primary Completion Date : June 13, 2021
Estimated Study Completion Date : December 11, 2022
I doubt they will risk their credibility by rushing any trial protocols.
Also their vaccine is based on RNA with its own set of problems https://www.nature.com/articles/s41586-020-2639-4
Personally, I see mRNA and Ii-key like a Ford Model T and a Rolls-Royce. Sure the Model T was first and it will get you from point A to point B, but which one would you rather drive/ride in? We will probably still have another year of mask wearing and social distancing. So play it safe, be smart and stay healthy!
(1)
(0)Scroll down for more posts ▼
